Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
7.60
-0.30 (-3.80%)
At close: Nov 18, 2025, 4:00 PM EST
7.61
+0.01 (0.07%)
After-hours: Nov 18, 2025, 4:07 PM EST
Lifecore Biomedical Market Cap
Lifecore Biomedical has a market cap or net worth of $284.74 million as of November 18, 2025. Its market cap has increased by 62.25% in one year.
Market Cap
284.74M
Enterprise Value
408.80M
1-Year Change
62.25%
Ranking
Category
Stock Price
$7.60
Market Cap Chart
Since December 1, 1998, Lifecore Biomedical's market cap has increased from $51.30M to $284.74M, an increase of 455.06%. That is a compound annual growth rate of 6.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 296.00M | 28.92% |
| Dec 31, 2024 | 229.60M | 22.32% |
| Dec 29, 2023 | 187.70M | -2.14% |
| Dec 30, 2022 | 191.80M | -41.35% |
| Dec 31, 2021 | 327.00M | 3.06% |
| Dec 31, 2020 | 317.30M | -3.76% |
| Dec 31, 2019 | 329.70M | 0.33% |
| Dec 31, 2018 | 328.60M | -5.19% |
| Dec 29, 2017 | 346.60M | -7.79% |
| Dec 30, 2016 | 375.90M | 17.62% |
| Dec 31, 2015 | 319.60M | -13.85% |
| Dec 31, 2014 | 371.00M | 15.58% |
| Dec 31, 2013 | 321.00M | 31.29% |
| Dec 31, 2012 | 244.50M | 70.98% |
| Dec 30, 2011 | 143.00M | -9.55% |
| Dec 31, 2010 | 158.10M | -3.89% |
| Dec 31, 2009 | 164.50M | -4.47% |
| Dec 31, 2008 | 172.20M | -50.66% |
| Dec 31, 2007 | 349.00M | 29.79% |
| Dec 29, 2006 | 268.90M | 42.50% |
| Dec 30, 2005 | 188.70M | 18.75% |
| Dec 31, 2004 | 158.90M | 13.58% |
| Dec 31, 2003 | 139.90M | 261.50% |
| Dec 31, 2002 | 38.70M | -36.87% |
| Dec 31, 2001 | 61.30M | 35.92% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |